PeptiVAX, a Vaccine Platform for Flexibly Targeting New & Emerging Infectious Disease

Time: 4:00 pm
day: Day Two

Details:

  • PeptiVAX is a platform based on peptide antigen coating of nonreplicating adenovirus for delivery of peptide vaccination in infectious diseases.
  • Costly and time-consuming genetic engineering of new vaccines to emerging infectious diseases is not required
  • A pancoronavirus vaccine strategy targeting existing and emerging strains of coronavirus utilizing novel antigens will be described

Speakers:

Paul Higham